André Landin-Malt is a Senior Scientist at Skylark Bio, where he works on developing innovative gene therapies. Since joining Skylark in 2021, André has helped build the company’s research capabilities from the ground up—designing pre-clinical and IND-enabling studies, setting up specialized labs, and training teams to tackle some of the toughest challenges in hearing loss and gene therapy.

André earned his Ph.D. in Molecular Biology and oncology from Université Paris Cité and has spent his career exploring how genes shape development and health. After studying craniofacial development at New York University College of Dentistry, he dedicated eight years at the University of Virginia to understanding the biology of hearing and deafness. Today, his work combines cutting-edge science with a passion for improving lives, using advanced techniques in genetics and inner ear research to bring new therapies closer to patients.